Mustafa Altınbaş

3PUBLICATIONS
46CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Sep 14, 2026
Real-world outcomes of ribociclib treatment in HR-positive/HER2-negative metastatic breast cancer: efficacy, safety, and prognostic factors.

|Aug 03, 2021
Immunogenicity and safety of the CoronaVac vaccine in patients with cancer receiving active systemic therapy.

Cengiz Karacin, Tulay Eren, Esra Zeynelgil

|Feb 04, 2021
Trastuzumab ± Capecitabine Maintenance After the First-Line Treatment of HER2-Positive Advanced Gastric Cancer: Retrospective Observational Real-Life Data of Turkish Oncology Group.

Mustafa Gürbüz, Erman Akkuş, Abdullah Sakin

Pageof 1

Frequent Collaborators

2 joint publications

Yakup Ergun

2 joint publications

Nuri Karadurmus

2 joint publications

Dogan Uncu

1 joint publications

Doğan Yazılıtaş

1 joint publications

Tulay Eren

1 joint publications

Esra Zeynelgil

1 joint publications

Goksen Inanc Imamoglu

1 joint publications

Ibrahim Karadag

1 joint publications

Fatma Bugdayci Basal

1 joint publications

Osman Sutcuoglu

Frequent Collaborators

2 joint publications

Yakup Ergun

2 joint publications

Nuri Karadurmus

2 joint publications

Dogan Uncu

1 joint publications

Doğan Yazılıtaş

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us